HDL和心血管疾病
Daniel J Rader1, G Kees Hovingh2
1Department of Medicine and Department of Genetics, Institute for Translational Medicine and Therapeutics, and Cardiovascular Institute, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
Lancet (London, England)
|August 19, 2014
概括
高密度脂蛋白 (HDL) 胆固醇与较低的心脏病风险有关,但其在动脉样硬化中的直接因果作用仍然不确定. 目前正在进行的研究和药物开发旨在澄清HDL.
科学领域:
- 心血管科学 心血管科学
- 脂质代谢 脂质代谢是什么
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 高密度脂蛋白 (HDL) 胆固醇与冠心病 (CHD) 风险相反相关.
- 高脂的动脉动脉保护性已得到充分证实,但其在动脉样硬化中的因果作用仍在争论中.
- 对高密度胆固醇假设的怀疑源于人类遗传学和临床试验结果.
研究的目的:
- 评估目前对HDL和动脉样硬化之间的关系的理解.
- 讨论最近发现和正在进行的高血糖向疗法研究的含义.
- 评估HDL调节药物在预防心血管疾病方面的潜力.
主要方法:
- 对人类遗传研究的审查.
- 对提高HDL的治疗方法的临床试验数据的分析.
- 检查针对HDL功能的新兴治疗策略.
主要成果:
- 临床试验的不一致结果使人们对HDL和动脉样硬化之间的直接因果关系产生了怀疑.
- 尽管存在不确定性,但针对高密度胆固醇的新型治疗干预措施正在临床开发中取得进展.
- 胆固醇转移蛋白 (CETP) 抑制剂正在后期发展.
结论:
- 高脂向治疗对冠状动脉心脏病事件的最终影响尚未确定.
- 需要进一步的研究来阐明HDL在心血管健康中的复杂作用.
- 提高HDL功能的药物的开发,包括逆胆固醇运输,显示了未来心血管风险管理的前景.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
751
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
751
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Hypertension II: Pathophysiology
1.7K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Heart Failure I: Introduction
1.5K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.5K

